The Global Antihistamine Drugs Market involves drugs that treat or prevent allergic conditions by blocking the action of histamine released by basophils and mast cells. Histamine is the major chemical mediator in allergy causing symptoms like sneezing, itching, rashes, runny nose and others. Antihistamines work by blocking the H1-receptor in the body where histamine is normally attached to cause allergic reactions. Common allergy conditions treated using antihistamine drugs include allergic rhinitis, conjunctivitis, chronic idiopathic urticarial and others. These drugs are available both as prescription and over-the-counter medications in forms of tablets, capsules, liquids and sprays. Some common categories include sedating antihistamines that cause drowsiness and non-sedating antihistamines.

The Global Antihistamine Drugs Market is estimated to be valued at US$ 78.89 BN in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Antihistamine Drugs Market are Bayer AG, Almirall S.A, GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer Inc., Sun Pharmaceutical Industries Limited, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, and Cipla. Key players such as Bayer AG, Almirall, and GlaxoSmithKline dominate the market with their wide variety of branded antihistamine drugs.

The increasing prevalence of various allergic disorders across the globe is driving the demand for antihistamine drugs. As per statistics, allergic rhinitis affects over 350 million people worldwide. Growing environmental pollution, changing demographics, and genetic factors are resulting in rising prevalence of conditions like asthma, urticaria, atopic dermatitis and food allergies.

The Global Antihistamine Drugs Market Demand is expanding globally with players focusing on emerging markets. Countries in Asia Pacific, Latin America, Middle East and Africa are witnessing significantly growing sales of antihistamine products due to enhancing access through e-commerce channels, awareness campaigns by governments and improving access to healthcare insurance.

Market drivers

The key driver driving the growth of the Global Antihistamine Drugs Market is the increasing prevalence of allergic disorders globally. As per a study, the incidence of allergic rhinitis, asthma, food allergies, atopic dermatitis and other allergic diseases has doubled in the past 20-30 years. The prevalence is higher in urban areas with developed country data showing up to 40% of adults and up to 30% of children being affected by at least one allergic disorder. Growing environmental pollution, changed lifestyle factors, and genetic predisposition are majorly attributed to this increase in allergic conditions. As the number of patients suffering from varied types of allergies is rising significantly, it is generating high demand for antihistamine drugs for effective treatment and management of related symptoms. This serves as a key driver for the market growth.

Get more insights, On Global Antihistamine Drugs Market

Check more trending articles related to this topic: Diagnostic Radioisotopes Market